Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

A physiologically based pharmacokinetic model for the broad-spectrum antimicrobial zinc pyrithione: I. Development and verification.

Diamond GL, Skoulis NP, Jeffcoat AR, Nash JF.

J Toxicol Environ Health A. 2017;80(2):69-90. doi: 10.1080/15287394.2016.1245123. Epub 2017 Jan 13.

PMID:
28085645
2.

Side effects from intense pulsed light: Importance of skin pigmentation, fluence level and ultraviolet radiation-A randomized controlled trial.

Thaysen-Petersen D, Erlendsson AM, Nash JF, Beerwerth F, Philipsen PA, Wulf HC, Paasch U, Haedersdal M.

Lasers Surg Med. 2017 Jan;49(1):88-96. doi: 10.1002/lsm.22566. Epub 2016 Jul 30.

PMID:
27474536
3.

Human health risk assessment of chloroxylenol in liquid hand soap and dishwashing soap used by consumers and health-care professionals.

Yost LJ, Rodricks JD, Turnbull D, DeLeo PC, Nash JF, Quiñones-Rivera A, Carlson PA.

Regul Toxicol Pharmacol. 2016 Oct;80:116-24. doi: 10.1016/j.yrtph.2016.06.003. Epub 2016 Jun 15.

PMID:
27316554
4.

Ultraviolet radiation after exposure to a low-fluence IPL home-use device: a randomized clinical trial.

Thaysen-Petersen D, Erlendsson AM, Nash JF, Beerwerth F, Philipsen PA, Wulf HC, Haedersdal M.

Lasers Med Sci. 2015 Nov;30(8):2171-7. doi: 10.1007/s10103-015-1796-4. Epub 2015 Aug 22.

PMID:
26296296
5.

Aggregate exposure modelling of zinc pyrithione in rinse-off personal cleansing products using a person-orientated approach with market share refinement.

Tozer SA, Kelly S, O'Mahony C, Daly EJ, Nash JF.

Food Chem Toxicol. 2015 Sep;83:103-10. doi: 10.1016/j.fct.2015.06.005. Epub 2015 Jun 16.

PMID:
26092325
6.

Quantitative assessment of growing hair counts, thickness and colour during and after treatments with a low-fluence, home-device laser: a randomized controlled trial.

Thaysen-Petersen D, Barbet-Pfeilsticker M, Beerwerth F, Nash JF, Philipsen PA, Staubach P, Haedersdal M.

Br J Dermatol. 2015 Jan;172(1):151-9. doi: 10.1111/bjd.13254. Epub 2014 Dec 13.

PMID:
25039260
7.

Relevance of UV filter/sunscreen product photostability to human safety.

Nash JF, Tanner PR.

Photodermatol Photoimmunol Photomed. 2014 Apr-Jun;30(2-3):88-95. doi: 10.1111/phpp.12113. Epub 2014 Feb 19. Review.

PMID:
24433498
8.

The role of natural and UV-induced skin pigmentation on low-fluence IPL-induced side effects: a randomized controlled trial.

Thaysen-Petersen D, Lin JY, Nash J, Beerwerth F, Wulf HC, Philipsen PA, Haedersdal M.

Lasers Surg Med. 2014 Feb;46(2):104-11. doi: 10.1002/lsm.22167. Epub 2013 Aug 23.

PMID:
24037900
9.

The agencies method for coalition formation in experimental games.

Nash JF Jr, Nagel R, Ockenfels A, Selten R.

Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20358-63. doi: 10.1073/pnas.1216361109. Epub 2012 Nov 21.

10.

The evolution of sunscreen products in the United States--a 12-year cross sectional study.

Wang SQ, Tanner PR, Lim HW, Nash JF.

Photochem Photobiol Sci. 2013 Jan;12(1):197-202. doi: 10.1039/c2pp25112d.

PMID:
23032968
11.

The 3T3 neutral red uptake phototoxicity test: practical experience and implications for phototoxicity testing--the report of an ECVAM-EFPIA workshop.

Ceridono M, Tellner P, Bauer D, Barroso J, Alépée N, Corvi R, De Smedt A, Fellows MD, Gibbs NK, Heisler E, Jacobs A, Jirova D, Jones D, Kandárová H, Kasper P, Akunda JK, Krul C, Learn D, Liebsch M, Lynch AM, Muster W, Nakamura K, Nash JF, Pfannenbecker U, Phillips G, Robles C, Rogiers V, Van De Water F, Liminga UW, Vohr HW, Wattrelos O, Woods J, Zuang V, Kreysa J, Wilcox P.

Regul Toxicol Pharmacol. 2012 Aug;63(3):480-8. doi: 10.1016/j.yrtph.2012.06.001. Epub 2012 Jun 9.

PMID:
22687423
12.

Laser and intense pulsed light hair removal technologies: from professional to home use.

Haedersdal M, Beerwerth F, Nash JF.

Br J Dermatol. 2011 Dec;165 Suppl 3:31-6. doi: 10.1111/j.1365-2133.2011.10736.x. Review.

PMID:
22171683
13.

A systematic review of light-based home-use devices for hair removal and considerations on human safety.

Thaysen-Petersen D, Bjerring P, Dierickx C, Nash JF, Town G, Haedersdal M.

J Eur Acad Dermatol Venereol. 2012 May;26(5):545-53. doi: 10.1111/j.1468-3083.2011.04353.x. Epub 2011 Nov 30. Review.

PMID:
22126235
14.

Human safety review of "nano" titanium dioxide and zinc oxide.

Schilling K, Bradford B, Castelli D, Dufour E, Nash JF, Pape W, Schulte S, Tooley I, van den Bosch J, Schellauf F.

Photochem Photobiol Sci. 2010 Apr;9(4):495-509. doi: 10.1039/b9pp00180h. Review.

PMID:
20354643
15.

Evaluation of the genotoxicity of the imidazole antifungal climbazole: comparison to published results for other azole compounds.

Pérez-Rivera AA, Hu T, Aardema MJ, Nash JF.

Mutat Res. 2009 Jan;672(1):27-39. doi: 10.1016/j.mrgentox.2008.09.011. Epub 2008 Oct 2.

PMID:
18950734
16.

Ultraviolet A radiation: testing and labeling for sunscreen products.

Nash JF, Tanner PR, Matts PJ.

Dermatol Clin. 2006 Jan;24(1):63-74. Review.

PMID:
16311168
17.

Human safety and efficacy of ultraviolet filters and sunscreen products.

Nash JF.

Dermatol Clin. 2006 Jan;24(1):35-51. Review.

PMID:
16311166
18.

The second ECVAM workshop on phototoxicity testing. The report and recommendations of ECVAM workshop 42.

Spielmann H, Müller L, Averbeck D, Balls M, Brendler-Schwaab S, Castell JV, Curren R, de Silva O, Gibbs NK, Liebsch M, Lovell WW, Merk HF, Nash JF, Neumann NJ, Pape WJ, Ulrich P, Vohr HW; European Centre for Validation of Alternative Methods.

Altern Lab Anim. 2000 Nov-Dec;28(6):777-814. No abstract available.

PMID:
11105201
19.

In vitro assessment of the broad-spectrum ultraviolet protection of sunscreen products.

Diffey BL, Tanner PR, Matts PJ, Nash JF.

J Am Acad Dermatol. 2000 Dec;43(6):1024-35.

PMID:
11100018
20.

Effect of daily versus intermittent sunscreen application on solar simulated UV radiation-induced skin response in humans.

Phillips TJ, Bhawan J, Yaar M, Bello Y, Lopiccolo D, Nash JF.

J Am Acad Dermatol. 2000 Oct;43(4):610-8.

PMID:
11004615
21.

The effects of radicals compared with UVB as initiating species for the induction of chronic cutaneous photodamage.

Ibbotson SH, Moran MN, Nash JF, Kochevar IE.

J Invest Dermatol. 1999 Jun;112(6):933-8.

22.

A review of sunscreen safety and efficacy.

Gasparro FP, Mitchnick M, Nash JF.

Photochem Photobiol. 1998 Sep;68(3):243-56. Review.

PMID:
9747581
23.

A toxicological review of topical exposure to white mineral oils.

Nash JF, Gettings SD, Diembeck W, Chudowski M, Kraus AL.

Food Chem Toxicol. 1996 Feb;34(2):213-25. Review.

PMID:
8606037
26.

A novel apparatus for measuring rat locomotor behavior.

Brodkin J, Nash JF.

J Neurosci Methods. 1995 Apr;57(2):171-6.

PMID:
7609580
27.

1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist.

Nichols DE, Frescas S, Marona-Lewicka D, Huang X, Roth BL, Gudelsky GA, Nash JF.

J Med Chem. 1994 Dec 9;37(25):4346-51.

PMID:
7996545
28.
29.

Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors.

Nash JF, Roth BL, Brodkin JD, Nichols DE, Gudelsky GA.

Neurosci Lett. 1994 Aug 15;177(1-2):111-5.

PMID:
7824160
30.
31.

Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity.

Brodkin J, Malyala A, Nash JF.

Pharmacol Biochem Behav. 1993 Jul;45(3):647-53.

PMID:
8101380
32.

Interaction of amfonelic acid with antipsychotic drugs on dopaminergic neurons.

Gudelsky GA, Nwajei EE, Defife K, Nash JF.

Synapse. 1992 Dec;12(4):304-11.

PMID:
1361248
33.
34.

Effect of buspirone on prolactin secretion is not mediated by 5-HT-1a receptor stimulation.

Meltzer HY, Lee HS, Nash JF Jr.

Arch Gen Psychiatry. 1992 Feb;49(2):163-4. No abstract available.

PMID:
1550467
35.

Neuroendocrinological and neurochemical effects of sigma ligands.

Gudelsky GA, Nash JF.

Neuropharmacology. 1992 Feb;31(2):157-62.

PMID:
1348112
36.

Effects of amfonelic acid and GBR 12909 on the haloperidol- and clozapine-induced activation of dopamine neurons.

Gudelsky GA, Nwajei EE, Defife K, Nash JF.

Psychopharmacol Bull. 1992;28(3):275-9.

PMID:
1480731
37.

Effects of antipsychotic drugs on serotonin receptors.

Meltzer HY, Nash JF.

Pharmacol Rev. 1991 Dec;43(4):587-604. Review. No abstract available.

PMID:
1685568
38.
39.

Free-choice ethanol consumption by rats: effects of ACTH4-10.

Krishnan S, Nash JF Jr, Maickel RP.

Alcohol. 1991 Sep-Oct;8(5):401-4.

PMID:
1665698
40.

Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues.

Nash JF, Nichols DE.

Eur J Pharmacol. 1991 Jul 23;200(1):53-8.

PMID:
1722755
41.

Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans.

Lee MA, Nash JF, Barnes M, Meltzer HY.

Psychopharmacology (Berl). 1991;103(2):258-64.

PMID:
1851310
42.

Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.

Nash JF, Arora RC, Schreiber MA, Meltzer HY.

Biochem Pharmacol. 1991 Jan 1;41(1):79-84.

PMID:
1702633
43.

Behavioral, biochemical and neurotoxicological actions of the alpha-ethyl homologue of p-chloroamphetamine.

Johnson MP, Huang XM, Oberlender R, Nash JF, Nichols DE.

Eur J Pharmacol. 1990 Nov 20;191(1):1-10.

PMID:
1982656
44.

Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder.

Bastani B, Nash JF, Meltzer HY.

Arch Gen Psychiatry. 1990 Sep;47(9):833-9.

PMID:
2203327
45.

Neuroendocrine measures of dopaminergic function in chronic cocaine users.

Lee MA, Bowers MM, Nash JF, Meltzer HY.

Psychiatry Res. 1990 Aug;33(2):151-9.

PMID:
2243892
46.

Reserpine-induced DST nonsuppression in rats.

Lowy MT, Nash JF Jr, Meltzer HY.

Biol Psychiatry. 1990 Mar 1;27(5):546-8. No abstract available.

PMID:
1968770
47.
49.

Selective cross-tolerance to 5-HT1A and 5-HT2 receptor-mediated temperature and corticosterone responses.

Nash JF Jr, Meltzer HY, Gudelsky GA.

Pharmacol Biochem Behav. 1989 Aug;33(4):781-5.

PMID:
2533356
50.

Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA).

Lowy MT, Nash JF Jr, Meltzer HY.

Eur J Pharmacol. 1989 Apr 12;163(1):157-61.

PMID:
2472965

Supplemental Content

Loading ...
Support Center